Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-01-24 @ 9:42 PM
Study NCT ID:
NCT00001118
Status:
COMPLETED
Last Update Posted:
2021-11-01
First Post:
1999-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Injections, Intravenous | View |
| None | Injections, Subcutaneous | View |
| None | Drug Therapy, Combination | View |
| None | HIV Protease Inhibitors | View |
| None | Membrane Fusion | View |
| None | Reverse Transcriptase Inhibitors | View |
| None | Anti-HIV Agents | View |
| None | Viral Load | View |
| None | peptide T20 | View |